miR-223-3p mediates the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway
Biochemical and Biophysical Research Communications · 2023-03 · 648 · 50-58
DOI: 10.1016/j.bbrc.2023.01.045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-03. Verfasst von Ping Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650031, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, MicroRNAs. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic kidney disease (DKD), the most pervasive complication in diabetic patients, has become a major health threat to the aging population. Our previous miRNA profiling identified hsa-miR-223-3p as a dysregulated miRNA in the DKD samples, which may serve as a biomarker for DKD diagnosis. However, the specific mechanism of miR-223-3p in the pathogenesis of DKD remains to be elucidated. In this study, we first verified that miR-223-3p level was significantly decreased in the in vitro cell model and in vivo db/db DKD model, accompanied with endothelial cell damage. Importantly, inhibiting the expression of miR-223-3p exacerbated high-glucose induced damages in Human Umbilical Vein Endothelial Cells (HUVECs) and Human Renal Glomerular Endothelial Cells (HRGECs), while miR-223-3p overexpression showed the opposite effect. We further demonstrated that miR-223-3p associated with IL6T mRNA and attenuated the progression of DKD by suppressing the downstream STAT3 activation, indicative of the implication of miR-223-3p/IL6T/STAT3 axis in the pathogenesis of DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650031, China.
- Department of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650031, China.
- Scientific Research Laboratory Center, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650031, China. Electronic address: sqs621@yeah.net.
- Department of Geriatric Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650031, China. Electronic address: lihuazhang772002@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tang, P., Xu, Y., Zhang, J., Nan, J., Zhong, R., Luo, J., Xu, D., Shi, S., & Zhang, L. (2023). miR-223-3p mediates the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway. Biochemical and Biophysical Research Communications, 648, 50-58. https://doi.org/10.1016/j.bbrc.2023.01.045
Vancouver
Tang P, Xu Y, Zhang J, Nan J, Zhong R, Luo J, et al. miR-223-3p mediates the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway. Biochemical and Biophysical Research Communications. 2023;648:50-58. doi:10.1016/j.bbrc.2023.01.045
BibTeX
@article{Tang2023,
author = {Tang, Ping and Xu, Yushan and Zhang, Jingrong and Nan, Juanli and Zhong, Ruxian and Luo, Jingmei and Xu, Dazhi and Shi, Shaoqing and Zhang, Lihua},
title = {miR-223-3p mediates the diabetic kidney disease progression by targeting IL6ST/STAT3 pathway},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
volume = {648},
pages = {50--58},
doi = {10.1016/j.bbrc.2023.01.045}
}
EUVIMED